A Phase I Trial With Escalating Doses of Oxaliplatin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Children and Adolescents With Extensive Colon Carcinoma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- 25 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 28 Jul 2016 Status changed from active, no longer recruiting to recruiting.
- 06 Jul 2016 Planned primary completion date changed from 1 May 2017 to 1 May 2018.